Overexpression of NLRP12 enhances antiviral immunity and alleviates herpes simplex keratitis via pyroptosis/IL-18/IFN-γ signaling
International Immunopharmacology · 2024-08 · 137 · 112428
DOI: 10.1016/j.intimp.2024.112428 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-08. Verfasst von Jiaxuan Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing 2100…. Hauptthemen laut MEDLINE: Pyroptosis, Keratitis, Herpetic, Interleukin-18, Interferon-gamma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nanjing University, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Herpes simplex keratitis (HSK) is a blinding disease caused by herpes simplex virus type 1 (HSV-1) infection, and rapid eradication of the virus from the affected cornea is imperative. Nod-like receptors (NLRs) are intracellular innate immune sensors closely associated with cell death, inflammation and immune responses. In this study, we investigated the role of NLRP12 in the antiviral immunology in HSK and the underlying mechanisms. We found that NLRP12 expression was significantly decreased in HSV-1-infected human corneal epithelial cells (HCE-Ts) and HSK mouse corneas. Overexpression of NLRP12 significantly reduced viral replication in infected HCE-Ts and functioned through inflammasome-mediated pyroptosis and downstream IL-18-IFN-γ axis. In HSK mouse models, overexpression of NLRP12 reduced viral replication in the cornea and alleviated HSK symptoms. This resulted from enhanced antiviral immune responses including the activation of specific immune cells in both the cornea and the draining lymph nodes. Specifically, the NLRP12-IL-18-IFN-γ axis regulated the interaction between infected corneal epithelial cells and macrophages. In conclusion, our study identified a role of NLRP12 in mediating pyroptosis and regulating antiviral immune responses. This novel finding opens the possibilities of NLRP12 as a viable target in the therapeutic strategies for HSV-1 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing 210008, China.
- Department of Ophthalmology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 321 Zhongshan Road, Nanjing 210008, China.
- Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing 210008, China. Electronic address: kai_hu@nju.edu.cn.
Förderung
- Nanjing University
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital
- Tufts Medical Center
Zitieren
APA
Jiang, J., Shen, W., He, Y., Liu, J., Ouyang, J., Zhang, C., & Hu, K. (2024). Overexpression of NLRP12 enhances antiviral immunity and alleviates herpes simplex keratitis via pyroptosis/IL-18/IFN-γ signaling. International Immunopharmacology, 137, 112428. https://doi.org/10.1016/j.intimp.2024.112428
Vancouver
Jiang J, Shen W, He Y, Liu J, Ouyang J, Zhang C, et al. Overexpression of NLRP12 enhances antiviral immunity and alleviates herpes simplex keratitis via pyroptosis/IL-18/IFN-γ signaling. International Immunopharmacology. 2024;137:112428. doi:10.1016/j.intimp.2024.112428
BibTeX
@article{Jiang2024,
author = {Jiang, Jiaxuan and Shen, Wenhao and He, Yun and Liu, Junpeng and Ouyang, Junwen and Zhang, Chengxiao and Hu, Kai},
title = {Overexpression of NLRP12 enhances antiviral immunity and alleviates herpes simplex keratitis via pyroptosis/IL-18/IFN-γ signaling},
journal = {International Immunopharmacology},
year = {2024},
volume = {137},
pages = {112428},
doi = {10.1016/j.intimp.2024.112428}
}
EUVIMED